top of page
Search Results

115 items found for "Nobel Prize"

  • Ep 27 with Dr. Robert J. Lefkowitz

    ., 2012 Nobel Prize in Chemistry, which he shared with Dr. Brian Kobilka . and we chatted for almost 2h about Bob’s career, discoveries, difficulties (yes, he’s had some too), Nobel to Stockholm: The Adrenaline-Fueled Adventures of an Accidental Scientist Duke University Wikipedia Nobel Prize HHMI Lefkowitz Lab Google Scholar Pubmed Dr.

  • Ep 91 with Dr. Oliver Hartley

    as a biochemist, he completed a PhD in protein engineering (Cambridge, UK) with Sir Gregory Winter (Nobel Prize for Chemistry, 2018).

  • Ep 01 with Dr. Paul Insel

    During dinner with colleagues and Alfred Gillman , co-recipient of the 1994 Nobel Prize in Physiology Today, Paul and his team focus on previously unrecognized receptors with the hopes to use these as novel

  • Ep 106 with Dr. Bruno Giros

    professor at Duke University in North Carolina, working with Marc Caron and Robert Lefkowitz (2012 Nobel Prize in Chemistry) to characterize several neurotransmitter transporters and kinases and establish and has received several distinctions, including the CNRS silver medal, the FRM "Young Researcher" prize

  • Ep 112 with Julia Gardner

    at as the first-ever summer intern at Septerna, the GPCR-based biotechnology company founded by Duke Nobel

  • Ep 49 with Dr. Sudha Shenoy

    Lefkowitz (Nobel Laureate, 2012) at Duke University. Dr.

  • Ep 42 with Dr. Randy Hall

    training at Duke University, where he studied the regulation of adrenergic receptors in the laboratory of Nobel Randy has received a number of research prizes, including the PhRMA New Investigator Award, the Distinguished

  • Ep 103 with Dr Kathleen Caron

    She pursued postdoctoral training with Nobel Laureate Dr.

  • "Have a nice weekend, and I'll see you tomorrow!": RAMP-interacting GPCR Pathways

    She pursued postdoctoral training with Nobel Laureate Dr.

  • Ep 66 with Dr. Antony A. Boucard Jr

    Alfred Gilman , Nobel Laureate for his discovery of G proteins, Dr.

  • GPCR Retreat 2023 - Part I

    to be working alongside the very talented team at Orion who translate important GPCR research into novel She pursued postdoctoral training with Nobel Laureate Dr.

  • Ep 38 with Dr. Alexander S. Hauser

    structural biology, pharmacology, and pharmacoepidemiology with innovative computational methods to gain novel Ph.D. with David Gloriam at the Department of Drug Design and Pharmacology in Copenhagen, he worked on novel He received the “HC Ørsted Research talent prize” and “Bayer Pharmaceuticals Ph.D.

  • Ep 43 with Dr. Stuart Maudsley

    At the end of his studies, he was awarded the Pfizer Prize for undergraduate research. At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based forming the basis of a new technology-based start-up company, HeptOME , to help screen and develop novel

  • Ep 72 with Dr. Stuart Maudsley

    At the end of his studies, he was awarded the Pfizer Prize for undergraduate research. At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based forming the basis of a new technology-based start-up company, HeptOME , to help screen and develop novel

  • Ep 78 with Dr. Stuart Maudsley

    At the end of his studies, he was awarded the Pfizer Prize for undergraduate research. At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based forming the basis of a new technology-based start-up company, HeptOME , to help screen and develop novel

  • G Proteins and GPCRs in Cancer: Novel Precision Targeted and Immunotherapies

    Contest Committee Sponsors GPCR Retreat Program < Back to schedule G Proteins and GPCRs in Cancer: Novel individual genomic and molecular alterations to develop new precision cancer treatments, and to identify novel

  • Ep 75 with Vaithish Velazhahan

    He has developed novel tools and methodologies to study fungal GPCRs which allowed the determination Vaithish has been recognized with the MRC LMB's Max Perutz Prize for outstanding Ph.D. work and has been

  • Ep 121 with Yao Lu (Jackie)

    Ph.D. student, at Monash University, Australia, investigating the role of functional selectivity in a novel Her work involves the pharmacological and structural characterisation of novel putative antipsychotic molecular explanation of small molecules for their pre-clinical efficacy and to support the design of novel

  • In Silico Design of Novel RGS2-Galpha-q Interaction Inhibitors with Anticancer Activity

    < GPCR News < GPCRs in Oncology and Immunology In Silico Design of Novel RGS2-Galpha-q Interaction Inhibitors

  • Ep 39 with Dr. Kathryn E Livingston

    Kathryn’s passion is developing solutions to problems in whatever form is most efficient: novel instrumentation , novel methods, or novel communication.

  • Ep 51 with Dr. Mark Connor

    Graeme Henderson (Bristol, opioids and Ca signaling) and Mac Christie (Sydney, opioids in neurons, novel Currently pursuing molecular pharmacology of phytocannabinoids and novel synthetic cannabinoids, with a focus on efficacy and novel targets.

  • GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment

    < GPCR News < GPCRs in Oncology and Immunology GPR68-ATF4 signaling is a novel prosurvival pathway in Here we interrogate the role of GPR68 specifically in GBM cells using a novel highly specific small molecule

  • Ep 44 with Dr. Steven Foord

    He also discovered and championed a novel prostaglandin EP4 drug candidate for development. He finished his career as Head of Bioinformatics for Neuroscience and working on the GSKs novel genetics

  • Trainee Symposium I

    Symposium I Date & Time Thursday, November 2nd / 1:45 PM - 2:45 PM Title: Virion Display to Discover a Novel GPCR Title: Characterization of Novel Opioid-Neurotensin Bifunctional Ligands Designed to Target Pain During his graduate studies, Emile is interested in characterizing novel G protein-coupled receptors

  • Ep 16 with Dr. Aaron Sato

    Aaron has a proven track record as a biologics leader as he led teams to discover and develop novel first-in-class technology to manufacture DNA at a scale, the team saw an opportunity to tackle the challenge of identifying novel

  • DANGER Signals Activate G-Protein Receptor Kinases Suppressing Neutrophil Function and Predisposing to Infection After Tissue Trauma

    We studied injury-induced immune dysfunction seeking novel means to reverse such predisposition. internalizing GPCRs and suppressing CTX. mtDNA suppresses CTX, phagocytosis and killing via TLR9 through a novel Conclusions: Tissue injury-derived DAMPs suppress antimicrobial immunity via canonical GRK2 activation and a novel

  • Ep 92 with Dr. Stephane Angers

    Moon , where he identified and characterized novel components of the Wnt signaling pathway and a new His pioneer work led to the development of novel antibody molecules blocking and activating the Wnt pathway

  • A2aR on lung adenocarcinoma cells: A novel target for cancer therapy via recruiting and regulating tumor-associated macrophages

    < GPCR News < GPCRs in Oncology and Immunology A2aR on lung adenocarcinoma cells: A novel target for that A2aR on LUAD cells drives TAMs migration and polarization, and blockade of A2aR may support a novel

bottom of page